| Up
2005P-0162:
ANDA SUITABILITY FOR DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE
ORAL SOLUTION USP, 5 MG/ 0.05 MG/ 5 ML.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
|
| CP1
|
| 04/26/2005
|
| 04/26/2005
|
| Drug Industry
|
| Lachman Consultant
Services, Inc.
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| Robert W. Pollock
|
|
|
|
|
| ACK1
|
| 04/26/2005
|
| 04/26/2005
|
| Federal Government
|
| HFA-305 to Lachman
Consultant Services, Inc
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
|
| Signature:
|
| Jennie C. Butler
|
|
Top
| Up
Page last updated
May 17, 2005
kk
Dockets Home Page | Dockets
Contacts and Location | Operating
Status | Item
Code Definitions | Federal
Register
FDA Home Page | Search
FDA Site | FDA A-Z Index
| Contact FDA
FDA/Dockets Management |
